KK B.M.L
4694
ISIN JP3799700004 / Valor 789977
KK B.M.L
UMushroom community rating:
About company
KK B.M.L is a Japanese company specializing in clinical laboratory testing and diagnostic services.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (14.08.2024):
Net Sales Decline
KK B.M.L's consolidated net sales for the fiscal year 2023, which ended on March 31, 2024, were ¥137,964 million. This represents a 13.5% decrease compared to the previous fiscal year. The decline in net sales was primarily due to a significant reduction in demand for COVID-19-related testing.
Operating Profit Drop
For the same period, KK B.M.L reported an operating profit of ¥9,167 million, marking a substantial 61.7% decrease year-on-year. The drop in operating profit was influenced by the reduced sales from COVID-19-related testing and increased costs of raw materials and energy.
Ordinary Profit and Net Income
KK B.M.L's ordinary profit for fiscal 2023 was ¥9,605 million, a 60.3% decrease from the previous year. The profit attributable to owners of the parent company also saw a significant decline, falling by 61.3% to ¥6,034 million.
Dividends
KK B.M.L declared a total dividend of ¥80.00 per share for fiscal 2023, down from ¥100.00 per share in the previous year. The dividend payout ratio increased to 51.7%, reflecting the lower earnings for the year.
Financial Position
As of March 31, 2024, KK B.M.L's total assets stood at ¥170,991 million, with net assets amounting to ¥130,140 million. The equity ratio improved slightly to 73.6%, up from 72.5% in the previous fiscal year, indicating a stable financial position despite the challenging operating environment.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
764 M
Market cap (USD)
51,900
Daily traded volume (Shares)
2893 / 2841
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
